A pioneering study analyzed chromatin immunoprecipitation followed by sequencing (ChIP-seq) data for TFs such as FOXA1 in multiple breast cancer cell lines, along with GWAS-identified risk variants. The gene discussed is FOXA1; the disease is breast carcinoma.